Target intelligence / Profile preview

Matrix protein 2 (Influenza A virus) (M2)

Target
M2
Molecular classification
Ion channel, Viroporin, Viral membrane protein
01

Overview

Matrix protein 2 (M2) of influenza A virus is a small, integral membrane protein that functions as a proton-selective ion channel (viroporin) and is essential for virus replication. The N-terminal 23-residue ectodomain (M2e) is highly conserved and exposed on the virion surface. M2 enables acidification of the virion interior during endocytosis by selectively transporting protons across the viral envelope in response to endosomal pH, triggering disassembly of ribonucleoproteins from matrix protein 1 and facilitating genome release into the host cell cytoplasm. M2 is also involved in maintaining trans-Golgi network pH, proper maturation of hemagglutinin (HA), efficient virus budding, and interaction with host cellular machinery. The M2 ion channel is targeted by adamantane antivirals, but clinical use is severely limited by widespread resistance. The M2e region is under investigation as a universal influenza A vaccine candidate due to its high conservation, though M2e-targeted vaccines rely on Fc-mediated effector mechanisms and do not provide sterilizing immunity.

Other names
Matrix-2 proteinProton channel protein M2M2 proton channelViroporin M2M2e (for the ectodomain, a subregion)
02

Mechanism of action

Blockade of M2 proton channel activity, inhibiting viral uncoating and genome release

03

Biological functions

Proton transport (hydrogen ion transmembrane transporter activity)Virus uncoating (pH-regulated dissociation of ribonucleoproteins from viral matrix)Virus budding and morphogenesisInflammasome activation
04

Disease associations

Infection (influenza A virus)Antiviral drug resistance
05

Safety considerations

Rapid emergence of drug resistance (notably S31N mutation)Limited efficacy of M2e-based vaccines (do not confer sterilizing immunity, dependent on Fcγ receptor-mediated immune mechanisms)
06

Interacting drugs

Amantadine

2 more in the full profile.

07

Biomarkers

M2e-specific antibody response (used for vaccine evaluation and infection monitoring)

Beyond the preview

Go deeper on Matrix protein 2 (Influenza A virus) (M2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix protein 2 (Influenza A virus) (M2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call